Publications by authors named "Saidu Kamara"

Claim this Profile
T
Targeted delivery and pro-apoptotic efficacy of an Epstein-Barr virus nuclear antigen 1-specific affibody in EBV-infected cells in vitro.
Luqi Zhou, Shangrong Yang, Changzhi Zhang, Wangqi Du, Saidu Kamara

Int J Biol Macromol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel affibody molecules targeting the AXL extracellular structural domain for molecular imaging and targeted therapy of gastric cancer.
HuiHui Zhang, Maolin Zheng, YiQi Cai, Saidu Kamara, Jun Chen

Gastric Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma.
Saidu Kamara, He Wen, Yanru Guo, Ying Liu, Lei Liu

Cells· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel anti-CEA affibody for rapid tumor-targeting and molecular imaging diagnosis in mice bearing gastrointestinal cancer cell lines.
Huanyi Shao, Kaiji Lv, Pengfei Wang, Jinji Jin, Yiqi Cai, Saidu Kamara

Front Microbiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma.
Saidu Kamara, Yanru Guo, He Wen, Ying Liu, Lei Liu

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of multi-module low density lipoprotein receptor class A domains with acid labile cyanopyridiniumylides (CyPY) as aspartic acid masking groups.
Kevin Neumann, Alex Vujinovic, Saidu Kamara, André Zwicky, Simon Baldauf

RSC Chem Biol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants.
Wangqi Du, Peipei Jiang, Qingfeng Li, He Wen, Maolin Zheng, Saidu Kamara

Microbiol Spectr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models.
Yanru Guo, Saidu Kamara, Jing Zhang, He Wen, Maolin Zheng

Front Cell Infect Microbiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma.
Saidu Kamara, Yanru Guo, Shanshan Mao, Xiaoxian Ye, Qingfeng Li

Appl Microbiol Biotechnol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells.
Jinshun Zhu, Saidu Kamara, Qi Wang, Yanru Guo, Qingfeng Li

Front Cell Dev Biol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabrication of Refractory Materials from Coal Fly Ash, Commercially Purified Kaolin, and Alumina Powders.
Saidu Kamara, Wang Wei, Chaoqian Ai

Materials (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.
Jinshun Zhu, Saidu Kamara, Danwei Cen, Wanlin Tang, Meiping Gu

Cell Death Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.
Jinshun Zhu, Saidu Kamara, Danwei Cen, Wanlin Tang, Meiping Gu

Cell Death Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.
Shanli Zhu, Jun Chen, Yirong Xiong, Saidu Kamara, Meiping Gu

PLoS Pathog· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis